 The bill also directed Medicaid and the Children’s Health Insurance Program's Payment and Access Commission report its data regarding doula care coverage under state Medicaid programs and subsequently develop strategies aimed at improving access to doula care.In February 2017, Gillibrand and thirty other senators signed a letter to Kaléo Pharmaceuticals in response to the opioid-overdose-reversing device Evzio rising in price from $690 in 2014 to $4,500 and requested the company answer what the detailed price structure for Evzio was, the number of devices Kaléo Pharmaceuticals set aside for donation, and the totality of federal reimbursements Evzio received in the previous year.In March 2017, Gillibrand was one of twenty-one senators to sign a letter led by Ed Markey to Senate Majority Leader Mitch McConnell which noted that 12 percent of adult Medicaid beneficiaries had some form or a substance abuse disorder in addition to one third of treatment administered for opioid and other substance use disorders in the United States being financed through Medicaid and opined that the American Health Care Act could "very literally translate into a death spiral for those with opioid use disorders" due to the insurance coverage lacking and not having the adequate funds to afford care oftentimes resulting in individuals abandoning substance use disorder treatment.